Clinical Trial Update: Stockholm3 Use Prior to MRI for Prostate Cancer Detection in a Clinical Care Pathway: a Multi-centered Validation

View source ↗

Summary

A multi-center validation study evaluating Stockholm3 as a pre-MRI risk stratification tool for detecting prostate cancer in a clinical care pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Karolinska Institutet | Conditions: Prostate Cancer | Status: NOT_YET_RECRUITING